Market Research Logo

Human Microbiome-based Drugs and Diagnostics: Global Markets

Human Microbiome-based Drugs and Diagnostics: Global Markets

The global market for human microbiome-based drugs and diagnostics should reach a market size of nearly $9.9 billion by 2024.

Report Includes
An overview of the global markets for human microbiome-based drugs and diagnostics.
Analyses of global market trends, with estimates from 2017, and projections of compound annual growth rates (CAGRs) through 2024.
Coverage of areas and applications where these technologies are applicable, such as cancer, diabetes, allergic disorders, irritable bowel disorders, celiac disease, and other G.I. disorders.
An in-depth look at macro-level trends affecting this sector.
Market intelligence on the technologies and platforms currently being deployed to develop these drugs and diagnostics.
Specific emphasis on the products in development for various diseases, including the specific forecasts for these products by disease and geography.
A look at the current level of investments in the sector, intellectual property development, and future of this sector.

Report Scope
The scope of the study includes the major microbiome-based drugs and diagnostics that are likely to be commercialized within the next eight years. Each product within each market is analyzed to determine its market status, market potential during the time period of 2018 to 2024. Microbiome intellectual property, investments and collaborations are discussed.

Influencing factors, industry structure, challenges facing the industry and patent status are discussed. BCC Research examines companies in the industry, corporate alliances and assay consumption by indication. We profile 25+ companies participating in this rapidly developing and evolving sector.


Chapter 1 Introduction
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Intended Audience
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
Related BCC Research Reports
Chapter 2 Summary and Highlights
Summary and Highlights
Chapter 3 Microbiome Overview
Microbiome Overview
Scientific Background
Human Microbiome in Health and Disease
Advances in Microbiome Research
Human Microbiome Project
MetaHIT Consortium
Public Sector Initiatives in Microbiome Research
Focus Areas for Microbiome-Based Drugs and Diagnostics
Microbiome-Based Drugs: Product Development Strategies
Current Challenges in Microbiome Drug Development
Chapter 4 Human Microbiome-Based Drugs Market
Cancer
Background
Microbiome and Cancer
Microbiome-based Drugs for Cancer: Review of Drugs in Development
Market for Microbiome-based Drugs for Cancer
Obesity
Background
Microbiome and Obesity
Microbiome-based Drugs for Obesity: Review of Drugs in Development
Market for Microbiome-based Drugs for Obesity
Type 2 Diabetes
Background
Microbiome and Type 2 Diabetes
Microbiome-based Drugs in Type 2 Diabetes: Review of Drugs in Development
Market for Microbiome-based Drugs for Type 2 Diabetes
Ulcerative Colitis and Crohn’s Disease
Background
Microbiome and Ulcerative Colitis/Crohn’s Disease
Microbiome-based Drugs for Ulcerative Colitis and Crohn’s Disease: Review of Drugs in Development
Market for Microbiome-Based Products for Ulcerative Colitis and Crohn’s Disease
Clostridium Difficle Infection
Background
Microbiome and Clostridium Difficle Infection
Microbiome-based Drugs for Clostridium Difficle Infection: Review of Drugs in Development
Market for Microbiome-based Drugs for Clostridium Difficle Infection
Lactose Intolerance
Background
Microbiome and Lactose Intolerance
Microbiome-based Drugs for Lactose Intolerance: Review of Drugs in Development
Market for Microbiome-based Product for Lactose Intolerance
Dental caries
Background
Microbiome and Dental Caries
Microbiome-based Drugs for Dental Caries Review of Drugs in Development
Market for Microbiome-based Products for Dental Caries
Recurrent Bacterial Vaginosis and Urinary Tract Infection
Background
Microbiome and Recurrent Bacterial Vaginosis and Urinary Tract Infection
Microbiome-based Drugs for Recurrent Bacterial Vaginosis and Urinary Tract Infection: Drugs in Development
Market for Microbiome-based Products for Recurrent Bacterial Vaginosis and UTI
Skin Diseases
Background
Microbiome and Skin Diseases
Microbiome-based Drugs for Skin Diseases: Review of Drugs in Development
Market for Microbiome-based Drugs for Skin Diseases
Hyperoxaluria
Background
Microbiome and Hyperoxaluria
Microbiome-based Drugs for Hyperoxaluria: Review of Drugs in Development
Market for Microbiome-based Products for Hyperoxaluria
Urea Cycle Disorder
Background
Microbiome and Urea Cycle Disorder
Microbiome-based Drugs for Urea Cycle Disorder: Review of Drugs in Development
Market for Microbiome-Based Drugs for Urea Cycle Disorder
Celiac Disease
Background
Microbiome and Celiac Disease
Microbiome-Based Drugs for Celiac Disease: Review of Drugs in Development
Market for Microbiome-based Products for Celiac Disease
Phenylketonuria
Background
Microbiome and Phenylketonuria
Microbiome-based Drugs for Phenylketonuria: Review of Drugs in Development
Market for Microbiome-based Products for Phenylketonuria
Non-alcoholic Steatohepatitis (NASH)
Background
Microbiome and Non-alcoholic Steatohepatitis
Microbiome-based Drugs for Non-alcoholic Steatohepatitis: Review of Drugs in Development
Market for Microbiome-based Products for Non-alcoholic Steatohepatitis
Microbiome-based Products for Hepatic Encephalopathy
Microbiome and Hepatic Encephalopathy
Microbiome-based Drugs for Hepatic Encephalopathy: Review of Drugs in Development
Market for Microbiome-based Drugs for Hepatic Encephalopathy
Chapter 5 Human Microbiome-based Diagnostics Market
Human MicrobiomeHuman MicrobiomeHuman MicrobiomeHuman MicrobiomeHuman MicrobiomeHuman MicrobiomeHuman MicrobiomeHuman MicrobiomeHuman MicrobiomeHuman MicrobiomeHuman MicrobiomeHuman Microbiome-based Diagnostics Marketbased Diagnostics Marketbased Diagnostics Marketbased Diagnostics Marketbased Diagnostics Marketbased Diagnostics Marketbased Diagnostics Marketbased Diagnostics Marketbased Diagnostics Marketbased Diagnostics Marketbased Diagnostics Market
Microbiome Diagnostics: Overview
Microbiome Diagnostics: Technologies
Microbiome Diagnostics: Applications
Microbiome Diagnostics: Industry Collaborations
Market for Microbiome Diagnostics
Microbiome-based Diagnostics for Ulcerative Colitis and Crohn’s Disease
Microbiome-based Diagnostics for Cancer
Microbiome Diagnostics for Women’s Health
Microbiome Diagnostics for Dental caries
Chapter 6 Microbiome Intellectual Property, Investments and Collaborations
Microbiome Intellectual Property, Investments and CollaborationsMicrobiome Intellectual Property, Investments and CollaborationsMicrobiome Intellectual Property, Investments and CollaborationsMicrobiome Intellectual Property, Investments and CollaborationsMicrobiome Intellectual Property, Investments and CollaborationsMicrobiome Intellectual Property, Investments and CollaborationsMicrobiome Intellectual Property, Investments and CollaborationsMicrobiome Intellectual Property, Investments and CollaborationsMicrobiome Intellectual Property, Investments and CollaborationsMicrobiome Intellectual Property, Investments and CollaborationsMicrobiome Intellectual Property, Investments and CollaborationsMicrobiome Intellectual Property, Investments and CollaborationsMicrobiome Intellectual Property, Investments and CollaborationsMicrobiome Intellectual Property, Investments and CollaborationsMicrobiome Intellectual Property, Investments and CollaborationsMicrobiome Intellectual Property, Investments and CollaborationsMicrobiome Intellectual Property, Investments and CollaborationsMicrobiome Intellectual Property, Investments and CollaborationsMicrobiome Intellectual Property, Investments and CollaborationsMicrobiome Intellectual Property, Investments and CollaborationsMicrobiome Intellectual Property, Investments and CollaborationsMicrobiome Intellectual Property, Investments and CollaborationsMicrobiome Intellectual Property, Investments and CollaborationsMicrobiome Intellectual Property, Investments and CollaborationsMicrobiome Intellectual Property, Investments and CollaborationsMicrobiome Intellectual Property, Investments and CollaborationsMicrobiome Intellectual Property, Investments and CollaborationsMicrobiome Intellectual Property, Investments and CollaborationsMicrobiome Intellectual Property, Investments and CollaborationsMicrobiome Intellectual Property, Investments and CollaborationsMicrobiome Intellectual Property, Investments and CollaborationsMicrobiome Intellectual Property, Investments and CollaborationsMicrobiome Intellectual Property, Investments and CollaborationsMicrobiome Intellectual Property, Investments and Collaborations
Intellectual Property
Overview
Microbiome Patent Segments
Patents by Disease Area
Investments and Collaborations
Investments: Overview
Public Sector Investments
Private Sector Investments
Collaborations: overview
Microbiome Public Databases Overview
Chapter 7 Company Profiles
Company Profiles
Lists of Tables and Figures
About BCC Research
About BCC Research
BCC Library Access
BCC Custom Research

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report